Company ProfilePremium

Liphatech Inc.

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Liphatech Inc. - Company showcase

Year Founded & Workforce

1946

Liphatech Inc. logo

Liphatech Inc. Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Liphatech Inc. Overview

Liphatech, Inc. is the Americas arm of the De Sangosse group's rodent-control franchise and, by its parent's own account, has become the leading rodenticide company in the United States. Its edge is upstream chemistry. The Liphatech lineage discovered three of the industry's anticoagulant active ingredients: chlorophacinone, bromadiolone and difethialone. Difethialone remains a proprietary, Liphatech-exclusive active in its professional range. Downstream, the company is known for formulation science; it brands itself "The Soft Bait Innovators" after pioneering the palatable soft-bait format (FirstStrike), which competitors later copied. The portfolio covers soft baits, mini-blocks, tamper-resistant Aegis bait stations, agricultural and field baits (Rozol), and CO₂ burrow fumigation (IGI CO₂). Since 2024–25 it has added a nascent insect-control line (Peritect 360 IC, BugScents). Liphatech sells through distribution to pest management professionals, animal-health and agricultural users. Its central strategic exposure is regulatory: tightening federal and state restrictions on anticoagulant rodenticides.


What the company does

Liphatech researches, registers, manufactures and markets pest-control products, mainly rodenticides and rodent-control systems, for professional and agricultural users across the Americas. The company describes itself as a worldwide manufacturer of pest-control products and the developer of three industry active ingredients (chlorophacinone, bromadiolone, difethialone) plus the palatable bait matrices that carry them. It says these together control rodents, slugs and snails (liphatech.com/history).

Company's own description

The company's standard boilerplate, used in press releases from 2021 to 2024, describes Liphatech as Milwaukee-headquartered, backed by the De Sangosse group, with a long history of advancing the science of rodent control and of pairing advanced technology with high customer service and technical support. The De Sangosse paragraph describes the parent as an international supplier of crop protection, plant nutrition and pest control products (press releases, Sep 2021; Jan 2022; Jun 2024). Since 2025 the self-description has shifted to "a longtime provider of intelligent pest control/management solutions" (press releases, Jul 2025; Apr 2026). This reflects the broader "Experienced People. Intelligent Solutions." brand vision that CEO Manny Martinez set out (Pest Management Professional interview).

Business model and revenue model

Revenue streamNatureEstimated mixBasis
Rodenticide baits (soft bait, mini-block, pellets, meal, place packs)Consumable product; recurring, route-based replenishment by PMPsDominant (likely majority). Exact share not publicly disclosedProduct catalogue; pallet-promotion structure
Bait stations (Aegis family) and placement devices (SST)Durable hardware that drives bait pull-throughMinority. Not publicly disclosedProduct catalogue
Agricultural / field rodenticides (Rozol, FastDraw, Cannon) and slug/snail bait (Metarex)Consumable; seasonal; restricted-use for some SKUsMaterial. Not publicly disclosedGrowing Produce; EPA labels
Fumigation (IGI CO₂ / Eliminator kits)Equipment kit plus consumable CO₂ pesticideSmall, emerging. Not publicly disclosedSep 2021 acquisition release
Insect control (Peritect 360 IC, BugScents)Consumable concentrate; monitoring traps, lures, glue boards (exclusive US distribution)Nascent. Not publicly disclosedPCT Online; liphatech.com/insect-control

Liphatech's model is product sales, not service, subscription or licensing. One indirect licensing-like element may exist: difethialone-based actives and technology are shared across De Sangosse group affiliates worldwide. Intercompany pricing is not disclosed. Promotion is built around annual pallet programmes, which give free product on full-pallet purchases (2025–26 programme: 1 Sep 2025–31 Aug 2026; 2026–27 programme: 1 Sep 2026–31 Aug 2027). Contests run through distributors, such as the Soft Bait Slam Dunk (2019) and the Soft Bait Challenge (2017), are also used. Both indicate a two-step distribution model: manufacturer → specialty distributor → pest management professional (PMP) or farm user.

Value-chain position

Liphatech is vertically integrated across the rodenticide chain in a way few competitors match:

  1. Active-ingredient discovery and ownership. Its lineage includes chlorophacinone (1960s), bromadiolone (1970s) and difethialone (1980s).

  2. Regulatory registration. It holds EPA FIFRA registrations under company number 7173, Canadian PMRA registrations, and Latin American registrations coordinated with partners.

  3. Bait-matrix formulation. This covers soft bait, mini-blocks and grain/pellet baits.

  4. Manufacturing. The group names Milwaukee (USA) and Agen (France) as its manufacturing sites.

  5. Commercialisation. Sales go through distributors, backed by a field technical sales force.

Customer types and end-markets

End-marketCustomerRepresentative products
Structural pest control (commercial and residential)Licensed PMPs, national pest-control accountsFirstStrike, Resolv, Flatline, TakeDown II, Generation, Maki, BlueMax, Aegis, IGI CO₂, Peritect, BugScents
Animal health (livestock and poultry facilities)Farm operators via animal-health distributionFastDraw, Cannon soft baits; Liphatech AG range
Agriculture / field and orchardGrowers, rangeland managers, ag retailersRozol (prairie dog, pocket gopher), Metarex slug and snail bait
Commodity storageFumigators / storage operatorsIGI CO₂ (insect control in commodity storage)
International (LatAm and Caribbean, Canada)DistributorsFull line, subject to local registration

Independent characterisation

Liphatech is best understood as a specialty-chemistry niche leader whose value rests on three moats: (a) regulatory dossiers, since EPA and PMRA registrations for anticoagulants are expensive and slow to replicate; (b) proprietary difethialone, a single-feed second-generation anticoagulant (SGAR) the company markets as exclusive; and (c) formulation and palatability know-how in soft baits. The flip side is concentration. Most of its value sits in anticoagulant chemistry that faces structural regulatory pressure, including EPA's proposed restricted-use classification for all SGARs and state-level outdoor-use bans. The insect-control and CO₂ fumigation moves from 2021 to 2026 read as deliberate hedges against that concentration.

Strategy

Stated strategic themes

ThemeExpressionSource
"Experienced People. Intelligent Solutions."Brand vision. Turns the team's intellectual capital (former PMPs, entomologists, scientists) into "intelligent solutions" beyond rodenticidesPMP interview with Manny Martinez
"The Soft Bait Innovators"Formulation leadership in palatable soft baitsCompany releases
Diversification beyond rodenticidesInsect control (Peritect, BugScents); CO₂ fumigation (IGI)PCT Online; Apr 2026 release
Customer service and technical expertiseRepeated emphasis on top-tier service and expert guidance for US and Canadian customersApr 2026 release
Continuity of leadershipInternal CEO succession; DSG philosophy of strong local leadership and entrepreneurial spiritSep 2026 release

Initiatives in the last 24 months (Oct 2024–Oct 2026)

InitiativeDateDescription
Insect-control market entryc. 2024–2025Peritect 360 IC launched as the first of a planned series of insect-control products
BugScents exclusive distribution2,025Exclusive US professional distribution of Arctech Innovation's bed-bug monitoring system
IGI CO₂ education pushDec 2025New overview, application and equipment-setup videos
Field-force expansionDec 2024; Jul 2025New district sales and technical managers
2025–26 and 2026–27 pallet programmesSep 2025; Sep 2026Volume-incentive programmes
Divisional leadership realignmentApr 2026Elderbrook to structural pest control
CEO successionSep 2026Dillon appointed at start of FY2027

ESG-related commitments

Liphatech positions Peritect as an option for "environmentally conscious" customers and NoTox as a non-toxic monitoring tool. It also complies with EPA endangered-species mitigation (e.g., black-footed ferret protections on Rozol labels). No quantified ESG targets are published.

Medium-term financial targets

Not publicly disclosed.

Products & Services

Note on actives: where the active ingredient is confirmed in a source reviewed, it is stated. Where it is not, it is marked "not confirmed in sources reviewed". EPA registration numbers are given only where a primary or traceable source exists.

Structural Pest Control — Soft Baits

ProductDescription / capabilitiesActive ingredientTarget customerLaunch / latest versionNotes
FirstStrike Soft BaitFlagship. The company calls it the industry's first palatable soft bait; labelled for Norway rats, roof rats, house mice; holds integrity in heat/coldDifethialone (25 ppm, Liphatech-exclusive per 2025 Product Guide)PMPs, national accountsMid-2000s (exact year not confirmed); 40 g pouch added Nov 2014; 4-lb bags Jun 2016EPA Reg. No. 7173-258 per a retail listing (secondary source)
Resolv BaitSoft bait for routine maintenance and moderate infestationsBromadiolone (company-lineage active; formulation AI not confirmed in sources reviewed)PMPsPre-2014; 40 g pouch Nov 2014; 12 g pouches in 4-lb bags Jun 2016—
TakeDown II BaitAcute (non-anticoagulant) rodenticide in soft-bait form; faster results than anticoagulants; for heavy and anticoagulant-resistant infestationsNot confirmed in sources reviewedPMPsTakeDown launched Oct–Nov 2016; "II" iteration later (date not disclosed)—
Flatline Soft BaitDescribed as the first and only chlorophacinone soft bait for the professional market; multiple-feed first-generation anticoagulantChlorophacinonePMPs (US and Canada)US Jan 2020; Canada Jul 2022; pail size Jun 2024Positioned for everyday use where SGAR use is restricted

Structural Pest Control — Mini-Blocks and Other Baits

ProductDescriptionActive ingredientNotes
Generation Bait (mini-blocks)Long-running mini-block line (company cites "over 30 years" of mini-blocks)Difethialone (25 ppm)Generation Block launched in Australia 2010 by affiliate
Maki BaitRodenticide bait rangeBromadiolone (lineage; formulation detail not confirmed)Listed in the 2021 company boilerplate
BlueMax BaitRodenticide bait rangeNot confirmed in sources reviewed—
BorderLine BaitListed in current rodent-bait menuNot confirmed in sources reviewed—
NoTox Non-toxic BaitNon-toxic monitoring bait and attractant (formerly "Rat and Mouse Attractant", renamed under NoTox Sep 2021)None (non-toxic)Monitoring; fits IPM/regulatory trends
Rozol Tracking PowderChlorophacinone tracking powder for in and around structuresChlorophacinoneHistoric EPA Reg. 7173-113

Bait Stations and Placement Devices

ProductDescriptionLaunch / notes
Aegis-RP Bait StationTamper-resistant rat stationCurrent
Aegis-RP Anchor Bait StationAnchored variant for secured outdoor placementCurrent
Aegis Rat Bait StationRat-size stationCurrent
Aegis Mouse Bait StationMouse-size stationCurrent
SoftSecure Technology (SST)Placement device holding soft bait inside stations; removes need for bait rods. Rodents feed through bars. 16-lb pails of 40 g FirstStrike/Resolv came with five SSTs (2016)Launched Nov 2014; enhanced Sep 2021

Aegis stations feature a universal key, which CEO Martinez cited as a company innovation (Pest Management Professional interview).

Fumigation

ProductDescriptionLaunch
IGI CO₂ Powered by LiphatechCompany describes it as the only 99.9% CO₂ gas of its kind approved by EPA as a pesticide; kills burrowing rodents in burrows, including next to occupied buildings; also positioned for commodity-storage insect control. Not registered in all 50 states at launchAssets acquired Sep 2021; training videos published Dec 2025; label revision dated Feb 2022 (V5 posted Sep 2025)
The EliminatorApplication equipment kit for IGI CO₂Acquired with IGI assets Sep 2021

Insect Control (new category)

ProductDescriptionModelLaunch
Peritect 360 ICBroad-spectrum, minimum-risk insecticide concentrate qualifying for FIFRA 25(b) exemption; indoor/outdoor against bed bugs (adults and nymphs), ants, fleas, mosquitoesOwn brand; linked to De Sangosse's 2022 stake in Pertinent Eco-Solutionsc. 2024–2025 (first Liphatech insect product)
BugScents Sentry ProReusable pheromone-lure bed-bug monitor; 360° entry, 60 thigmotactic channels; detection in 24–96 hours; lures last ~3 monthsExclusive US professional distributor for Arctech Innovation Ltd (UK); developed with London School of Hygiene & Tropical Medicine2,025
BugScents Bed Bug AttractantReplacement pheromone lureAs above2,025
BugScents Glue BoardsReplacement glueboards (change every 2–3 months)As above2,025

Agricultural & Animal Health (Liphatech AG)

ProductDescriptionNotes
FastDraw Soft BaitSoft bait for animal-health/farm marketsNamed in ag division hiring release
Cannon Soft BaitSoft bait for animal-health/farm marketsNamed in ag division hiring release
Rozol Prairie Dog BaitChlorophacinone 0.005% bait for black-tailed prairie dogs on rangeland; hand application ≥6 inches down active burrows; carcass-search requirementsEPA Reg. No. 7173-286; Restricted Use; permitted in CO, KS, NE, OK, TX, WY only (since Aug 2011)
Rozol Pocket Gopher Bait / Bait IIIChlorophacinone bait for pocket gophers only; endangered-species restrictions in prairie-dog towns within ferret rangeEPA Reg. No. 7173-184 (amended 2007); Bait III registered 14 Feb 2011
Metarex Slug & Snail BaitThe company calls it the world's leading slug and snail baitGroup flagship molluscicide

Pricing

Liphatech does not publish list prices. Distribution pricing is set by distributors. One secondary-market listing showed a 4-lb FirstStrike bag at USD 55 (eBay, May 2025), which is indicative only. Promotional economics: free product with full-pallet purchases of select products (2025–26 and 2026–27 programmes).

Services

Technical support and field advisory through district sales and technical managers, plus training content (e.g., IGI CO₂ application videos, Dec 2025). No fee-based services are disclosed.

Financial Narrative

Disclosure status

Liphatech, Inc. is a private US subsidiary of an unlisted French group. It does not publish an income statement, balance sheet or cash-flow statement. No figure below is estimated or modelled. Year cells left blank in the chartable tables mean not publicly disclosed. Fiscal years end 31 August (FY2026 = 1 Sep 2025–31 Aug 2026).

Income statement (Liphatech, Inc.)

Revenue CAGR: not publicly disclosed. The only public revenue indication is a third-party aggregator band of USD 50M–100M (Seamless.ai; undated). It should not be used as a reported figure.

Ratios (Liphatech, Inc.)

ROE, ROA, ROIC, current ratio, debt/equity, net debt/EBITDA, interest coverage, asset turnover and cash conversion cycle: not publicly disclosed / cannot be computed.

Parent-level reference data (De Sangosse) — for context only

These are parent figures, not Liphatech figures. They come from French registry aggregators for the De Sangosse SA single legal entity (French operating company; fiscal year ends 31 August), not the consolidated group.

Sources and caveats:

  • FY2015–FY2019 come from Businesscoot (fiscal year end 31/08, 12-month periods).

  • The FY2020–FY2022 values come from Le Journal des Entreprises, which lists five unlabelled years: 140.384, 101.404, 94.457, 85.351, 96.407. The last two match Businesscoot's FY2019 and FY2018, so the chronological mapping to FY2020–FY2022 is inferred, not stated by the source.

  • Le Journal des Entreprises gives net income of EUR 19.945M and headcount of 196 for the latest year, and gross operating margin rates of 12.8%, 8.9%, 1.0%, -1.3%, -0.3% in the same newest-first order.

  • Blank FY2020–FY2021 net profit cells are not disclosed in the sources reviewed.

Source: PCT Online (June 2016), which cites 2015 group revenue of USD 386M and 780 employees, operations in 15 countries, and sales in 50 countries.

Commentary

There is no audited financial history for Liphatech. Three qualitative signals stand out:

  1. Commercial momentum. DSG's CEO said in September 2026 that Liphatech had "transformed itself into the leading rodenticide company in the United States" under Martinez. The claim is self-reported and unaudited.

  2. Investment posture. Continuous field-force hiring (2021–2025), an asset acquisition (IGI, 2021), and a new insect-control category (2024–26) imply the business is cash-generative enough to fund diversification.

  3. Parent profitability. The parent's French operating entity showed revenue rising from ~EUR 85M (FY2019) to ~EUR 140M (latest, likely FY2022) and a gross operating margin rate of 12.8% in the latest year. This points to a healthy group context, though it says nothing directly about Liphatech's margins.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Group Structure

LevelEntityRole

Ultimate parent

De Sangosse (France; SIREN 300163896); supervisory board chaired by Christophe Maquin; group CEO Nicolas Fillon

Crop protection, plant nutrition, adjuvants, biocontrol, bait technology, pest control

Americas subsidiary

Liphatech, Inc. (Milwaukee)

Rodent/insect control for Canada, USA, Mexico, Caribbean, Central and South America

Sister affiliate

Liphatech S.A.S. (Pont-du-Casse, France)

Rodenticides for rest of world (Europe, Africa, Middle East, Asia)

Sister affiliate

Liphatech Australia/NZ (est. 2005)

Australia/New Zealand

Related

Nutrient Technologies (acquired by De Sangosse Dec 2015)

Specialty plant nutrition (US)

Related

Pertinent Eco-Solutions (stake acquired by De Sangosse 2022)

Minimum-risk insect control technology

Division Overview

DivisionContentsLeadership (latest disclosed)

Structural Pest Control (Pest Management Division)

Soft baits, mini-blocks, Aegis stations, SST, NoTox, IGI CO₂ for structural use, insect control (Peritect, BugScents)

Matt Elderbrook, Business Manager (from Apr 2026); previously Matt Titshaw (from Apr 2022) and Charlie Passantino (business director from 2016)

Agricultural / Animal Health (Liphatech AG)

FastDraw, Cannon soft baits; Rozol line; Metarex slug and snail bait

Jason Burnette hired as business director, agricultural division (date not confirmed); Elderbrook led animal health for ~6 years before Apr 2026; successor not disclosed

Fumigation

IGI CO₂ / Eliminator kits (burrowing rodents; commodity-storage insect control)

—

International (Latin America and Caribbean)

Full line subject to registrations

Daniel De Poli, Business Manager LatAm (from Jun 2022)

Canada

Full line via liphatech.ca

District sales management (Nick Fugate, from Jan 2021)

“—” = not publicly disclosed.

Income Statement

MetricFY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022

De Sangosse SA revenue (EUR Mn, single entity)

199.5118.0101.296.485.494.5101.4140.4

De Sangosse SA net profit (EUR Mn, single entity)

15.915.57.16.56.7——19.9

Income Statement and Operating Metrics (count)

MetricFY2015

De Sangosse group consolidated revenue (USD Mn)

386

De Sangosse group employees (count)

780

Region Overview

RegionDirection (qualitative)Evidence

United States

Core market; described by DSG as "one of DSG Group's most strategic markets worldwide" and the market where Liphatech is the leading rodenticide company

Liphatech release 15 Sep 2026

Canada

Expansion: Flatline launched Jul 2022; pail format Jun 2024; dedicated Canada district sales coverage since Jan 2021

Press releases

Latin America and Caribbean

Development: dedicated business manager hired Jun 2022 to expand sales and coordinate registrations with partners

Pest Management Professional

US states with tightening rules (e.g., California, Maine)

Likely pressure on outdoor/residential anticoagulant use; Maine enacted LD 356 (signed 8 Jun 2025) directing a ban on rodenticides in outdoor residential settings

Maine Board of Pesticides Control documents

Capital Markets

ItemStatus

Share price performance (1/3/5-year)

Not applicable (not listed)

Analyst consensus

None (no coverage)

Dividend history / policy

Not applicable; upstream dividends to parent not disclosed

Credit ratings (Moody's/S&P/Fitch)

Not rated; none identified for Liphatech or De Sangosse

Metric

FY2022

Analyst Conclusions

Management guidance

None published. Qualitative direction from management (Apr 2026): continued focus on "diversified and innovative solutions" and unchanged service priority for US and Canadian customers. DSG (Sep 2026) expects a "next stage of growth" under Dillon.

Consensus expectations

None (no coverage).

Bull case

  1. Regulation as moat. RUP status for SGARs would raise barriers for consumer-oriented and smaller rivals. Liphatech's professional-channel focus and registration depth could let it take share in a narrower, higher-value market.

  2. Hedged portfolio. Flatline (FGAR soft bait), TakeDown II (acute), IGI CO₂ (fumigant) and NoTox (monitoring) cover the substitution paths that restrictions open, so regulatory pressure may move demand within Liphatech's catalogue rather than away from it.

  3. Diversification upside. Insect control is a much larger PMP spend category than rodent control. Even a modest share, built on existing distributor and PMP relationships, could add materially to a business the aggregator estimates at only USD 50M–100M.

Bear case

  1. Core chemistry under siege. Difethialone and bromadiolone are both SGARs targeted by the EPA, by NGOs (NWF 2026) and by states (Maine 2025). Further state bans could cut outdoor volumes in key markets.

  2. Diversification is thin. The insect line is two products, one of them a distributed third-party technology, in a crowded market dominated by large agrochemical players.

  3. Transition and opacity. A CEO change after 11 years, combined with no public financials, makes it hard to verify momentum or detect deterioration early.

Catalysts and monitorables (next 12 months)

  • EPA proposed or final RUP classification for rodenticides, and any interim decisions in registration review.

  • USFWS biological opinion following EPA's final BE.

  • Additional state outdoor-residential rodenticide bans (following Maine's lead).

  • New insect-control launches, the promised "series" after Peritect.

  • IGI CO₂ state registration expansion.

  • Early strategic signals from CEO Jennifer Dillon (organisation, investment, M&A).

  • Any De Sangosse group-level disclosures (results, acquisitions) that reference the US business.

Analyst verdict

Liphatech, Inc. is a high-quality, regulation-exposed specialty franchise, and the input list's "public company" label is wrong: it is a privately held subsidiary of France's De Sangosse. Its strategic value is clearer than its financial profile. On the strategic side, the facts are robust. Few companies in any agrochemical niche can claim to have discovered three of their industry's principal active ingredients, still hold one of them as an exclusive professional offering, and also have pioneered the dominant formulation format. The parent's public assertion in September 2026 that Liphatech is now the leading rodenticide company in the United States is unaudited, but it is consistent with the visible evidence: a broad registered catalogue, sustained field-force investment, a bolt-on acquisition (IGI, 2021) and a steady cadence of product extensions.

The investment-grade question is durability. Since the 2008 EPA decision, US rodenticide policy has moved one way, toward narrower SGAR use. The 2022 proposed interim decisions, the 2024 biological evaluation, Maine's 2025 law and the 2026 NWF resolution show that direction continuing. Liphatech's answer is credible on paper: chlorophacinone soft bait, an acute bait, CO₂ fumigation, non-toxic monitoring and an embryonic insect line. None of these hedges yet appears large enough to offset a severe contraction in SGAR demand, and none can be measured from public data.

The leadership handover to Jennifer Dillon, an internal operator whose background spans regulatory affairs, R&D, quality and production, fits a company whose next phase will be decided as much by compliance as by marketing. Net assessment: strategically well-positioned, with execution and regulatory risk skewed to the downside and opacity that rules out quantitative valuation. Stakeholders such as suppliers, distributors and potential acquirers should treat the EPA's RUP decision and the insect-control build-out as the two variables that will define Liphatech's next five years.


SOURCES REFERENCED

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameTitleTenurePrior roles / backgroundSource

Jennifer Dillon

Chief Executive Officer

CEO since 1 Sep 2026; ~12 years with Liphatech

Leadership across HR, Quality, IT, Safety, Regulatory Affairs, R&D, Customer Service and Graphics; more recently Operations and Production; exposure to commercial, marketing and financial management

Liphatech release 15 Sep 2026

Manny Martinez

CEO (retired)

~15 years at Liphatech; CEO ~2015–Aug 2026

Executive director from Jan 2013 (pest management, R&D, international sales); prior pest-management industry experience; built export business

Liphatech release Sep 2026; PMP Jan 2013

Matt Elderbrook

Business Manager, Structural Pest Control

Since 9 Apr 2026; 8-year Liphatech veteran; in structural pest control since 2006

Business Manager, Liphatech AG (animal health) for ~6 years

Liphatech release Apr 2026

Matt Titshaw

Business Manager, Structural Pest Control (from Apr 2022)

With Liphatech since 2016

National Sales Manager; Southeast District Sales Manager; Associate Certified Entomologist. Current role after Elderbrook's appointment not disclosed

Liphatech release Apr 2022

Daniel De Poli

Business Manager, Latin America

Since Jun 2022

BWI Companies (business manager, export and Florida); Univar Solutions (director, LatAm Export Services); 20+ years in industry

PMP Jun 2022

Jason Burnette

Business Director, Agricultural Division

Date not confirmed

—

Growing Produce

Kevin Hintz

Senior Marketing Manager, Structural Pest Control

Named in 2022–2024 releases

—

Press releases

Charlie Passantino

Business Director, Pest Management Division (from 2016)

Named through Jan 2021

Current status not disclosed

PCT Online 2016; Jan 2021 release

Nicolas Fillon

CEO, De Sangosse Group (parent)

Current

—

Liphatech release Sep 2026; theorg.com

“—” = not publicly disclosed.

Board & Management Changes

DateChangeContext

1 Sep 2026 (announced 15 Sep 2026)

Dillon succeeds Martinez as CEO

DSG frames it as continuity and internal talent development

9 Apr 2026

Elderbrook to Business Manager, Structural Pest Control

Linked to insect-market expansion

17 Jul 2025

Brandon Green hired, South Central District Sales and Technical Manager

Field-force build-out

19 Dec 2024

Alex Blahnik hired, Ohio Valley District Sales Manager

Field-force build-out

Competitive Landscape

Key Competitors

CompetitorTypeOverlap with LiphatechRevenue (relevant)

Bell Laboratories, Inc. (Madison, WI)

Private

Professional and ag rodenticides, bait stations — the most direct US rival

—

Syngenta (Professional Pest Management)

Private (ChemChina/Sinochem-owned)

Professional rodenticides

Segment not separately disclosed

BASF (Pest Control Solutions)

Listed (Xetra: BAS)

Professional rodenticides

Segment not separately disclosed

Envu (formerly Bayer Environmental Science)

Private (PE-owned)

Professional pest-control products incl. rodenticides

—

Neogen Corporation

Listed (NASDAQ: NEOG)

Animal-health/farm rodenticides

Rodenticide revenue not separately disclosed

Motomco

Private

Rodenticides (consumer/professional)

—

PelGar International (UK)

Private

Rodenticide actives and baits

—

SenesTech, Inc.

Listed (NASDAQ: SNES)

Rodent fertility control (non-lethal alternative)

—

Woodstream (Victor) / Kness / J.T. Eaton

Private

Traps, stations, mechanical alternatives

—

Insect control (25(b) and bed-bug monitoring) — various

Mixed

Peritect / BugScents overlap

Not applicable

“—” = not publicly disclosed.

Peer Comparison FY2022

MetricLiphatechBell LaboratoriesSyngenta PPMBASF Pest Control

Proprietary rodenticide active

Yes (difethialone; historic chlorophacinone, bromadiolone)

Formulator

Formulator / actives

Actives incl. novel non-anticoagulants

Soft-bait leadership

Pioneer

Strong

Present

Present

Recent Developments

Material industry and regulatory events that directly affect Liphatech are included and flagged "(Industry)".

Litigation, guidance revisions, layoffs and restructurings in the window: none disclosed.

Company Snapshot

1946

Founded

WI, US

Headquarters

SWOT Analysis

Strengths

  • Proprietary active ingredient. Difethialone at 25 ppm is marketed as Liphatech-exclusive (2025 Product Guide).
  • Discovery heritage. The company discovered three of the eight major rodenticide actives in use (Professional Pest Manager).
  • Soft-bait first mover. FirstStrike is cited as the first palatable soft bait; the format was later adopted by all major manufacturers.
  • Market leadership claim. DSG's CEO (Sep 2026) says Liphatech is the leading US rodenticide company.
  • Agricultural registrations. Rozol Prairie Dog (EPA 7173-286) and Pocket Gopher Bait III (registered Feb 2011) are hard-to-replicate niche franchises.
  • Strategic parent. De Sangosse, founded 1926, had USD 386M revenue in 2015 across 15 countries (PCT 2016). Its single entity showed a 12.8% gross operating margin rate in the latest year.

Weaknesses

  • Chemical concentration. Most named products are anticoagulants (FirstStrike, Resolv, Flatline, Generation, Maki, Rozol).
  • Opacity. No public financials, which limits external stakeholder confidence.
  • Ag-product regulatory history. Rozol Prairie Dog lost four states in Aug 2011 after litigation (Defenders of Wildlife v. Jackson).
  • IGI CO₂ footprint. Not registered in all 50 states at acquisition (Sep 2021 release).
  • Insect line depends on third parties. BugScents is an Arctech product under distribution; Peritect stems from a parent-level stake.
  • Leadership transition risk. CEO change at the start of FY2027, after an 11-year CEO tenure.

Opportunities

  • SGAR restrictions favour FGAR soft bait. Flatline is positioned as a chlorophacinone alternative where SGAR use is restricted (Jun 2024 release).
  • Non-chemical/burrow control. IGI CO₂ can be used next to occupied buildings, according to the company.
  • Insect control expansion. Peritect is described as the first in a series of insect products (PCT Online).
  • LatAm growth. A dedicated business manager since Jun 2022 is coordinating registrations.
  • Canada. Product rollouts (Flatline 2022, pails 2024).
  • Monitoring/IPM. NoTox non-toxic bait fits regulatory pushes toward monitoring-first IPM.

Threats

  • EPA RUP proposal. Would cover all SGARs, including difethialone and bromadiolone (Nov 2022 PIDs).
  • Endangered Species Act mitigation. Final BE (Nov 2024) and possible USFWS biological opinions.
  • State bans. Maine LD 356 (Jun 2025), plus other states' SGAR restrictions noted by NWF (Jun 2026).
  • NGO campaigns. NWF Resolution 2026-05; the earlier WWF petition (2009).
  • Competition from multinationals with broader portfolios (BASF, Syngenta, Envu) and the direct rival Bell Laboratories.
  • Substitution by mechanical, fertility-control (SenesTech) and exclusion-based IPM approaches.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
Nov 2024 (context)(Industry) EPA releases final Biological Evaluation for rodenticidesSets the endangered-species mitigation framework affecting all Liphatech anticoagulants
19 Dec 2024 (context)Alex Blahnik hired, Ohio Valley District Sales ManagerMidwest coverage
Early 2025 (expected)(Industry) EPA expected to propose Restricted Use Pesticide classification changes for rodenticidesCould restrict SGAR sales to certified applicators
May 2025Secondary-market price point for FirstStrike 4-lb observed (USD 55)Indicative pricing only
8 Jun 2025(Industry) Maine Governor signs LD 356, directing prohibition of rodenticides in outdoor residential settingsState-level demand erosion risk
17 Jul 2025Brandon Green hired, South Central District Sales and Technical ManagerContinued field build-out
12 Aug 2025BugScents Sentry Pro featured as distributed by Liphatech across the USInsect-control commercialisation
29 Aug 2025Trade advertorial announces two insect-control products for the US marketPublic positioning of diversification
1 Sep 20252025–26 Pallet Promo begins (to 31 Aug 2026)FY2026 volume programme
Sep 20252025 Full Line Product Guide published (difethialone 25 ppm exclusivity; insect-control milestones)Portfolio refresh
Sep 2025IGI CO₂ label (V5) re-postedFumigation category maintenance
3 Oct 2025(Industry) Maine Board of Pesticides Control reviews rodenticide regulatory overviewImplementation of LD 356
Dec 2025Three new IGI CO₂ training videos releasedAdoption support for non-anticoagulant tool
Dec 2025(Industry) Maine draft LD 356 rodenticide report to BoardFurther state rulemaking
9 Apr 2026Matt Elderbrook named Business Manager, Structural Pest ControlLeadership realignment after insect expansion
Jun 2026(Industry) National Wildlife Federation Resolution 2026-05 calls for strong federal and state SGAR restrictionsRising NGO pressure
31 Aug 2026FY2026 endsResults not disclosed
1 Sep 2026Jennifer Dillon becomes CEO; FY2027 beginsLeadership transition
1 Sep 20262026–27 Pallet Promo begins (to 31 Aug 2027)FY2027 volume programme
15 Sep 2026Public announcement of Martinez retirement and Dillon succession; DSG CEO calls Liphatech the leading US rodenticide companyParent endorsement

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Income Statement

2 charts
Income Statement (FY2015–FY2022): De Sangosse SA revenue fell from EUR 199.5 Mn in FY2015 to EUR 140.4 Mn in FY2022.
Liphatech Inc. — Income Statement (FY2015–FY2022)
Series (EUR Mn)FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022
De Sangosse SA revenue199.5118101.296.485.494.5101.4140.4
De Sangosse SA net profit15.915.57.16.56.7——19.9

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.